This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
While venture funding for digital health technology declined globally by 35% in the first three quarters of 2022 compared with 2021, this marks a “return to normal” based on the assessment in the Global State of Digital Health Report from FINN Partners and Galen Growth, published today and launched during the HLTH 2022 conference.
PatientSupport Services: These teams within pharmaceutical manufacturers provide dedicated resources to help patients access and afford the prescribed medications. This includes operating patient assistance programs that offer copay assistance, free drug supplies, and connections to independent charitable foundations.
In fiscal year 2022, Cencora provided over $6.3 At Cardinal Health, the company’s Sonexus Access and PatientSupport program develops tailored solutions to help patients get on, and stay on, prescription medication therapies.
PatientView, based in the UK, has collaborated with over 40,000 patient advocacy organizations globally marking over 10 years doing this research. A tenth indicator, patientsupport during the COVID-19 pandemic, was added in this year’s study. Support and services. Transparency.
Following the program, the company asked her to give a talk at their global leadership summit in January 2022. Fast-forward to her diagnosis in 2014 with Stage IV colorectal cancer, when Stacy emerged as an expert advocate due to her previous personal and professional experience.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content